# A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072

> **NCT05017662** · NA · COMPLETED · sponsor: **Ariceum Therapeutics GmbH** · enrollment: 20 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT05017662
- **Lead sponsor:** Ariceum Therapeutics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-14
- **Primary completion:** 2025-04-29
- **Final completion:** 2025-04-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017662, "A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05017662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*